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INTRODUCTION:  Femoral  head  osteonecrosis  is  associated  with  signiﬁcant  sequelae  for the  patient  in
the  long-term.  A combination  of  factors  are  thought  to contribute  to the pathophysiology  behind  this
debilitating  disease  process.





arthroplasty  within  3  years  of diagnosis  of  acute  lymphoblastic  leukaemia  that ran a complicated  course
of  multimodality  treatment.
DISCUSSION: The  case  examines  the  literature  on  femoral  head  osteonecrosis  in this  population  cohort  and
the  challenge  for  the  orthopaedic  surgeon  in the  management  of  this  increasingly  prevalent  condition.
CONCLUSION: In a  young  population  cohort,  it is important  to have  arthroplasty  surgery  as  part  of  the
management  armamentarium,  especially  when  coupled  with  complex  pathology.
gical © 2012 Sur
. Introduction
Femoral head osteonecrosis is associated with signiﬁcant seque-
ae for the patient in the long-term. A combination of factors are
hought to contribute to the pathophysiology behind this debilitat-
ng disease process. We  report on a 16-year-old adolescent male
equiring staged bilateral hybrid hip arthroplasty within 3 years of
iagnosis of acute lymphoblastic leukaemia that ran a complicated
ourse of multimodality treatment. The case examines the litera-
ure on femoral head osteonecrosis in this population cohort and
he challenge for the orthopaedic surgeon in the management of
his increasingly prevalent condition.
. Presentation of case
We report on a male patient that presented at the age of
3 to the paediatric services after developing a series of vague
ymptoms, complaining of generalised weakness, intermittent
bdominal pain and polyarthropathy with fatigue, having lost
 kg in the preceding month. Clinically he was pale with a non-
ender hepatosplenomegaly of approximately 3 cm.  There was
o lymphadenopathy and an otherwise normal systemic eval-
ation. Haematological proﬁle showed a pancytopaenia (Hb of
.1 g/dL, WBC  of 2.6 × 109 L–1, ANC of 0.4 × 109 L–1 and platelets of
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99 × 109 L–1) and hyperuricaemia (uric acid of 633 mol/L (range
150–330)) for which uric oxidase was given and rehydration ther-
apy commenced. A diagnosis of acute lymphoblastic leukaemia
(ALL) was made following a bone marrow analysis. Immunophe-
notype and histochemical studies indicated an early pre-B cell
ALL subtype with cytogenic studies showing high hyperdiploidy. A
course of multimodality treatment was commenced within 10 days
of presentation. The treatment protocol was  based on UKALL 2003
regime B induction chemotherapy of four drugs—dexamethasone,
vincristine, asparaginase and doxorubicin. Subsequent consolida-
tion/intensiﬁcation and maintenance phase treatment followed
over the next 38 months. A total of 2.64 g of dexamethasone was
given over this time frame. Within 3 weeks following induction
treatment (at which time 330 mg  or 12.5% of the total quantity
of steroid had been administered) the patient began to com-
plain of groin pain and had a right-sided limp. Plain imaging
revealed a grade I right-sided slipped capital femoral epiphysis
(SCFE) (Fig. 1) for which he went on to have an in situ pinning and
contralateral pinning 1 month later for similar symptoms. Within
2 months following the second surgery he represented with bilat-
eral lateral hip to groin pain and a pyrexia. Plain radiographs
revealed progression of the SCFE on the right (from grades I to
II) with epiphyseal collapse (Fig. 2) and subsequent investiga-
tions revealed a septic arthritis of the hips bilaterally. Cultures
grew coagulase negative staphyloccocus aureus. He went on to
Open access under CC BY-NC-ND license.have both pins removed with subsequent multiple washouts and
debridements over a 4-month period with selective intravenous
antibiotic therapy (intravenous Vancomycin 10 mg/kg followed
by Linezolid 10 mg/kg and Ciproﬂoxacin 15 mg/kg orally). The
 BY-NC-ND license.
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Fig. 3. An AP view showing bilateral osteonecrosis and femoral head collapse with
signiﬁcant osteopaenia.
Fig. 4. A follow-up AP image that shows bilateral tapered wedge press-ﬁt femoral
iatrogenic shift of physeal physiology at an age where the physisig. 2. An anteroposterior (AP) radiograph of bilateral SCFE pinning at follow-up
ith  progression of a grade I to grade II slip on the right and epiphyseal collapse.
atient continued with his cycles of chemotherapy throughout
his time. At the age of 16 and following 38 months of cyclic
hemotherapy and in remission, he continued to complain of
iffuse joint pains with progressive inability to ambulate sec-
ndary to pain and decreased range of motion of both hips, being
heelchair bound at presentation to the orthopaedic services. Plain
maging revealed osteonecrotic collapse of the femoral heads bilat-
rally (Fig. 3). Having considered the options, he underwent a
wo-stage primary hybrid hip replacement using an uncemented
emoral component (Accolade; Stryker Orthopaedics, Mahwah,
J) and a cemented acetabular component (Exeter Contempo-
ary Ultra-High-Molecular-Weight (UHMW)  ﬂanged cup; Stryker,
owmedica, UK) with a 32 mm alumina head (Stryker, Howmed-
ca, UK) on the right and interval procedure on the left side (Fig. 4).
mpaction grafting with morcelised femoral head allograft on the
cetabular side was required. Intraoperatively, there was  no evi-
ence of macroscopic infection with negative gram stains. This
as conﬁrmed postoperatively with microscopic analysis. The
atient is now 3 years on from the second arthroplasty proce-
ure and is doing well. He is mobilising and fully weight bearing
naided with a normal gait pattern and equal leg lengths. Abduc-
or and quadricep power has returned to normal. He remains in
emission.components with 32 mm alumina femoral heads articulating with acetabular
UHMW  components. Impaction grafting is noted.
3. Discussion
The current multidisciplinary and intensive multimodality
treatment for ALL has progressively improved the survival rate from
approximately 10% in the early 1970s1 to 80% at 5 years in 2008.2
Achieving these high survival rates over a relatively short period
has refocused attention on the potential toxic effects of treatment
intensiﬁcation in this subgroup of patients. The potential long-term
musculoskeletal sequelae can be devastating in a young popula-
tion cured from this form of malignancy. This poses a signiﬁcant
challenge for the Orthopaedic Surgeon.
The literature has described how hormonal imbalance can
change physeal physiology3 in adolescence. Harper et al. published
work in the 1980s suggesting that chemotherapy agents alone may
be responsible in the pathophysiology of avascular necrosis of the
femoral head, amongst other sites.4 Several studies have linked
osteonecrosis to the UKALL treatment regime for ALL,5–8 which was
used in this case. Is it possible that the SCFE occurred due to anwidens and periosteum thins9 within 3 weeks following chemos-
teroidal treatment, both of which being implicated in the literature
 –  O
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n the pathogenesis of ON. Several other studies cite a combina-
ion of chemoradiotherapy as a causal factor for ON regardless
f the type of cancer or the age of the patient.10–12 Ojala et al.
eport a 32% incidence (9/28) of osteonecrosis (ON) in a paedi-
tric population undergoing treatment for ALL of which 14.3% were
ymptomatic.13 All patients that developed ON in their cohort were
n the intermediate to high risk category and received a combina-
ion of chemotherapy (vincristine, doxorubicin, cyclophosphamide,
ercaptopurine, cytosine, teniposide and methotrexate), steroidal
reatment and cranial irradiation.13 Gebhard and Maibach suggest
hat steroids are the key player in atraumatic ON in the femoral
ead.14 Overall, there is a lack of consensus in the literature on
he aetiopathogenesis of ON in these patients.15,16 In this case,
 combination of factors are likely to have played a role in the
apid deterioration to end-stage ON of the femoral head bilater-
lly. The patient received a combination of high dose steroids and
olychemotherapy at an age of pubertal growth. Surgery was  indi-
ated for the slip at a time of maximum immunosuppression from
oncurrent treatment, increasing the risk of peri-operative infec-
ion. The post-operative complicated course of events following
CFE pinning led to the decision for staged unilateral followed by
ontralateral arthroplasty surgery.
. Conclusion
This group of young, adolescent patients are a challenge to
he orthopaedist. They have an underlying malignant condition
hat requires an intensive, potentially curative, medical treatment
egime, the long-term consequences of which can carry signiﬁcant
ebilitating sequelae. Even in an adolescent patient, it is important
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